General Discussions

Assessing Barriers to Oral Oncolytic Adherence

By Kathy Oubre, MS, Chief Operating Officer, Pontchartrain Cancer Center
PUBLISHED WEDNESDAY, DECEMBER 31, 1969


From financial toxicity to lifestyle, there are many factors that could prevent patients from consistently taking their medication. Kathy Oubre, MS, Chief Operating Officer, Pontchartrain Cancer Center in Covington, Louisiana, shares some barriers to adherence to oral oncolytics that patients may face.

There’s no way a checklist can be as comprehensive as it needs to be to cover all possible influential factors, Oubre said. Having a conversation with patients is the best way to get a clear understanding of what their barriers might be and how to overcome them.

 
Start a discussion
You must log in to use this feature, please click here to login.
External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
OncNurse Resources

Newsroom
Continuing Education
Discussions
Web Exclusives


About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2018
Intellisphere, LLC. All Rights Reserved.